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and urgency, and/or incomplete bladder 
emptying. Among spinal cord injured 
(SCI) patients, who frequently have uri-
nary retention, regaining bladder func-
tion has been reported as one of their 
highest priorities.[1,2] Patients with SCI 
also typically cannot sense bladder or 
bowel fullness and risk having leakage 
if they get overfilled. In a recent study 
led by the Craig H. Neilson Founda-
tion, developing an implantable sensor 
capable of detecting the fullness of 
the bladder or bowel was stated to be 
is of critical importance to the SCI 
patient population.[3] Such an implant-
able sensor might provide input to any 
existing neuromodulation devices or 
be part of alternative devices such as 
direct bladder stimulators. In this work, 
we chose to develop a direct bladder 
interface integrating strain sensor and 
stimulation electrode array to address 
the condition known as detrusor under-
activity. The implantable strain sensor 
alone may also benefit many other con-
ditions or applications.
Patients diagnosed with detrusor underactivity, which causes 
weak bladder contractions that can lead to retention, who do 
not respond to conservative treatments like medications and 
physical therapy are often recommended to use intermittent 
catheterization to empty their bladders. Although catheteriza-
tion is a standard treatment, bladder infection rates are high, 
it is uncomfortable, and can be burdensome. For patients that 
are unable to self-catheterize for any of these reasons, their 
The bladder, stomach, intestines, heart, and lungs all move dynamically to 
achieve their purpose. A long-term implantable device that can attach onto an 
organ, sense its movement, and deliver current to modify the organ function 
would be useful in many therapeutic applications. The bladder, for example, 
can suffer from incomplete contractions that result in urinary retention with 
patients requiring catheterization. Those affected may benefit from a com-
bination of a strain sensor and electrical stimulator to better control bladder 
emptying. The materials and design of such a device made from thin layer 
carbon nanotube (CNT) and Ecoflex 00–50 are described and demonstrate its 
function with in vivo feline bladders. During bench-top characterization, the 
resistive and capacitive sensors exhibit stability throughout 5000 stretching 
cycles under physiology conditions. In vivo measurements with piezoresis-
tive devices show a high correlation between sensor resistance and volume. 
Stimulation driven from platinum-silicone composite electrodes successfully 
induce bladder contraction. A method for reliable connection and packaging of 
medical grade wire to the CNT device is also presented. This work is an impor-
tant step toward the translation of low-durometer elastomers, stretchable CNT 
percolation, and platinum-silicone composite, which are ideal for large-strain 
bioelectric applications to sense or modulate dynamic organ states.
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1. Introduction
Organ disorders can be caused by a great variety of neuro-
logic and non-neurologic events such as peripheral neu-
ropathy, spinal cord injuries, multiple sclerosis, stroke, 
diabetes, complications of surgery, and simply aging. For one 
specific organ, bladder dysfunction can have a severe effect 
on individuals, leading to urinary incontinence, frequency 
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only option is the use of indwelling catheters which leads to 
greater health risks.[4] The exact prevalence of detrusor under-
activity is unknown, but underactive bladder, a weak bladder 
muscle in neurologically intact patients, has been estimated 
as occurring in 20–40% of adult men and women.[5,6] Surgical 
interventions such as implanted devices to stimulate nerves 
have been a last option for treatment. An implant that applies 
electrical stimulation to the S3 sacral nerve, known as sacral 
neuromodulation, has shown the best efficacy for underactive 
bladder,[7] however it does not provide on-demand assistance 
with bladder emptying and has had poor results in SCI patients 
and others with neurogenic bladders.[8] Electrical stimulation of 
the ventral roots has been used for effective bladder emptying 
in SCI patients,[9] however its invasive surgery requiring sacral 
rhizotomy (destruction of all the native nerve roots) has lim-
ited its use. In contrast, direct stimulation of the bladder wall 
holds potential for effective and immediate control over bladder 
emptying. Prior studies have had challenges with lead migra-
tion, recruitment of other pelvic structures or smooth muscle 
due to current spread, or ineffective emptying.[10,11] Fortunately, 
advances in stretchable bioelectronics, particularly in materials 
and fabrication, present new opportunities for direct bladder 
interface.[12–14] Furthermore, the use of stretchable bioelec-
tronics also holds promise for detecting the state of the bladder, 
allowing for closed-loop control over continence and more inde-
pendence for users.
There are many approaches developed by material scientists 
and engineers to achieve robust and stretchable electrical con-
nections,[15,16] including serpentine metal patterns,[17] wavy, 
buckled,[18] origami structures,[19] or ultrathin layer metals.[20] 
Greater strain performance has been demonstrated with con-
ductive polymers[21] and nanowire or nanoparticle percolation 
networks.[22–24] Carbon nanotubes (CNTs) are another mate-
rial for percolation networks, with large aspect ratio structures 
and many unique physical and chemical properties that have 
attracted a significant amount of fundamental material science 
and engineering studies on their synthesis, characterization, 
and integration. CNTs have inspired scientists to create both 
flexible microelectronics,[25–27] and large-strain sensors.[28–30] 
For implantable biomedical applications, several innovative 
material and fabrication solutions have successfully demon-
strated stretchable devices.[31] Compared with most of the tech-
nologies above, CNT percolation networks may hold several 
key advantages such as inert chemical properties, a large elastic 
range, and high flexibility.[32] Technologies for building layers 
of CNT include chemical vapor deposition growth,[33] spray 
coating,[34] inkjet printing,[35] and roll-to-roll/stamping.[36]
Highlighted by the outstanding dynamic range and respon-
sivity, CNT thin-layer conductors show great potential as a 
flexible and stretchable strain detector for wearable electronics 
applications. To our best knowledge, no examples of applying 
CNT percolation network for implantable stretchable elec-
tronics have been reported. Several important scientific and 
engineering issues have yet to be addressed by past research. 
The reliability and stability of the bare or polymer encapsu-
lated CNT percolation network in physiological conditions is 
unknown. Failure of the interfacial adhesion and voids in the 
structure could cause large changes in sensor responsivity or 
open or shorted circuits. A reliable electrical interconnection 
also has not yet been demonstrated. Finally, a robust adhesion 
method that allows a fragile, thin-film device built from low-
durometer materials to be secured onto moving organs without 
tearing either the device or the tissue is needed. This work 
addresses each of these issues. We utilized the low-durom-
eter Ecoflex 00–50 substrate (Smooth-on Inc., shore hardness 
00–50), CNT percolation network, a platinum nanoparticle 
composite, and superalloy wires to create a functional demon-
stration of bladder activity sensing and control.
The concept of a direct bladder stimulation array is to access 
a portion of the bladder surface and suture the perimeter of 
a stretchable array over the bladder dome and/or posterior 
wall (Figure 1). Unlike a wrap-around bladder sensor,[14,37] this 
approach requires less surgical time and less risk to the con-
nected nerves and blood vessels, making it potentially more 
suitable for clinical translation. Additionally, a bladder dome 
location for one or more arrays is more clinically translat-
able than other locations due to ease of surgical access. The 
built-in sensor detects the bladder wall strain. When the level 
of strain corresponds to a near-full state, a wireless communi-
cator would indicate this to the patient so a convenient location 
and time may be found before bladder stimulation and mictu-
rition was programmed to begin. Clinical development would 
also need a wireless implantable pulse generator (IPG) and a 
nerve cuff for electrical stimulation that would relax the ure-
thral sphincter during voiding,[38,39] which were not developed 
here. This work moves the field forward by demonstrating 
improved sensor stability and substrate robustness and dis-
cusses the merits of piezocapacitive and piezoresistive sensors 
in this application.
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Figure 1. Closed-loop bladder control concept and schematic. This work 
demonstrated the bladder wall component of this system that includes 
strain sensing and stimulation. Additional arrays on the dome and/or 
posterior wall of the bladder would increase stimulation capabilities of 
the system. Electronic control, wireless telemetry, and a sphincter stimu-
lator would be required for human translation.
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2. Results and Discussion
We demonstrated two types of organ strain-sensing devices. 
One deployed a piezoresistive approach with a single CNT 
layer, and the other deployed capacitive strain sensing with two 
layers (Figure 2). Each sensor type also has four or more stim-
ulation electrodes for delivering current and causing muscle 
contractions. The basic principle of the resistive device, as 
demonstrated in Dharap et al.[40] is that the resistance of the 
CNT resistor increases with increasing strain due to changes in 
the number of conductive paths in a percolation network. Simi-
larly, the capacitance of two parallel CNT layers increases with 
increasing strain as the electrode layers expand and the dielec-
tric layer thins during expansion.[41] Each device had an area of 
19.2 mm by 9.6 mm and four stimulation electrodes 2 mm in 
diameter (Figure 2).
The bench-top and in vivo performances, mechanical prop-
erties, reliability, and stability of the device in a physiological 
environment are discussed in the following sections.
2.1. Mechanical Properties
Since the bladder expands considerably,[42,43] any implant 
attached on the bladder wall must induce only a negligible 
amount of force and minimally alter the system mechanics. 
To determine the bulk material of the device, we conducted 
elasticity measurements of feline and porcine bladder sam-
ples and compared this to PDMS (Sylgard 184) prepared at a 
20:1 ratio and Ecoflex 00–50 (Figure S1a, Supporting Informa-
tion). All the samples were 2 cm long with a cross-section of 
3 mm by 1.2 cm. The total tensile force applied horizontally 
on one end of the tissue as a function of tissue expansion 
was recorded. PDMS (Sylgard 184), as one of the most com-
monly used soft elastic silicone materials, was far too stiff at 
100 µm thickness, while Ecoflex 00–50 has a significantly lager 
elastic range and 1/16 the stiffness of PDMS prepared at a 20:1 
ratio. The thickness of the Ecoflex substrate was empirically 
tested from 100 µm to 2 mm in thickness. We selected a thick-
ness of 300 µm considering the fracture strain (over 250%), 
elastic modulus and handling properties during implantation 
(Figure S1b, Supporting Information). Despite its industrial-
grade manufacturing, several studies have shown promising 
results for the biocompatibility of Ecoflex silicone.[44,45] When 
a 300 µm Ecoflex substrate was attached to a feline bladder 
wall and the bladder was fully expanded, we observed no defor-
mation in the bladder’s curvature (Figure S1c, Supporting 
Information).
Previous research successfully attached low-durometer 
material devices by directly suturing through the device sub-
strate into the bladder wall.[46] Initially, we attached either 
PDMS or Ecoflex substrates onto an ex vivo porcine bladder 
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Figure 2. Simplified fabrication process of a) resistive-type sensing device with stimulation; b) capacitive-type sensing device with stimulation. c) A 
resistive device sutured on feline bladder wall during in vivo test. Six 1 mm × 1 mm white pledgets, a PTFE matrix commonly used for suture rein-
forcement, are visible on the perimeter. d) Snapshot of the capacitive device array on wafer during fabrication. Insets show the single device of each 
type. e) SEM images of the CNT layer and the Pt/PDMS flexible stimulation electrode on top of the CNT/metal layer.
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with medical suture using a similar approach. However, local 
tearing in the substrate was evident after 2–5 cycles because of 
the high local stress around each suture attachment location. 
Medical grade cyanoacrylate or other glues may help secure 
a substrate to the bladder with less local deformation, but it 
would also impede current flow at the electrode–tissue inter-
face. Instead, we applied commercially available pledgets (small 
PTFE pads; 1.5 × 1.5 mm) at pre-defined locations around the 
perimeter. Each location was marked with a small CNT/Au pat-
tern (Figure 2d) and six pledgets were glued using a drop of 
Ecoflex 00–50. This technique eliminated tears in the substrate 
when attached with suture to feline or porcine bladders. One ex 
vivo porcine bladder experiment and four in vivo feline experi-
ments with around ten full-strain cycles each were conducted 
using devices with attached pledgets, and no visible tearing 
around suture sites occurred.
2.2. Device Functionality and Repeatability During Strain Cycle
We conducted bench-top and in vivo experiments to evaluate 
the performance of the bladder strain sensor. Both piezoresis-
tive and piezocapacitive devices were immersed in PBS (phos-
phate-buffered saline) solution heated to body temperature, 
clamped at each end, and repeatedly stretched from 0% to 
100% strain (setup described in Figure S3, Supporting Informa-
tion). The impedance of each sensor type was recorded for 5000 
cycles at this condition. Before any high-strain use, both device 
types needed to go through 5–20 pre-stretching cycles (N = 16 
devices) to stabilize and reorient the percolation network. The 
resistance changes during this process are shown in Figure 3 
for an example device. A similar need for pre-stretching cycles 
was reported in previous studies.[30,47]
Capacitive and Resistive CNT Sensors for Strain Detection: 
All devices were strained from 0 to 100% in the longitudinal 
direction. Equivalence to a 100% longitudinal strain with no 
transverse constraint was estimated to be approximately 78% 
biaxial strain (ΔS/S, where S is the area) based on total area 
change. The capacitive devices measured an increase in strain 
from capacitance change due to a combination of two effects, 
decrease of the dielectric layer thickness and increase of the 
electrodes effective surface area from stretching. Four capaci-
tive devices were tested during the bench-top experiments 
and demonstrated good repeatability (Figure 4b). Although 
a variance of absolute capacitance values at the free state was 
observed, the normalized capacitance showed very similar 
and repeatable strain response among devices (N = 4). Sensor 
responsivity which is the capacitance change per unit strain was 
calculated using equation dC/dε (Figure 4a). Despite variances 
introduced by fabrication, the device can be easily calibrated by 
dividing the zero-strain impedance. The relative capacitance, 
C/C0, increased from 1.0 to 2.13 ± 0.20 (N = 4) in response to 
the same range of longitudinal strain.
As for the resistive devices, during the expansion and con-
traction of the substrate, the tensile and compressive stress 
induced a re-orientation process in the CNT network, where 
each individual CNT repositioned to adapt the macroscopic 
strain. As a consequence of this dynamic configuration, the 
quantities of the conductive pathway within the CNT resistor 
changed with strain, which resulted in a non-linear change in 
the resistance.[48] Comparing with conventional thin-film or 
microelectromechanical system (MEMS) compatible materials 
for piezoresistive applications,[49,50] the obtained CNT network 
exhibited a much larger dynamic range while maintaining a 
large gauge factor. Similar to the capacitive devices, the normal-
ized resistance R/R0 can be used as a reliable measurement of 
strain regardless of absolute value variance among devices.
Bench-top testing showed a reversible and repeatable piezore-
sistive effect (Figure 5). Same as the capacitive device, the sensor 
responsivity was calculated using equation dR/dε (Figure 5a). The 
relative resistance, R/R0, of the CNT sensors increased from 1.0 
to 5.1 ± 0.18 (N = 6) in response to longitudinal strain from 0% to 
100%. The piezoresistive type sensor exhibited higher sensitivity 
albeit not as linear as the capacitive response. Neither measure-
ments showed a significant shift in the impedance versus strain 
curve after 5000 cycles (Figures 4d and 5d), suggesting that fur-
ther cycling could be achieved. The resistive devices also exhib-
ited more fluctuation than the capacitive devices in the abso-
lute impedance value during cycling (Figures 4c and 5c). The 
reason for the drift in impedance was likely a long-term drift of 
the CNT network configuration at microscale, while the capaci-
tance, or total effective electrode surface area and dielectric layer 
thickness, was less sensitive to the network configuration. Both 
types of the devices showed a high overall responsivity at 350.5 Ω 
(Figure 5a) and 2.1 pF (Figure 4a) per percentage strain, but the 
former is significantly easier to measure.
Stability in Physiological Environment: It is a highly crit-
ical factor for any implantable device to remain stable in a 
physiological environment. To examine this concern, we col-
lected a series of sensor output data while three devices were 
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Figure 3. Pre-stretching a CNT conductor. Normalized resistance of a 
500-µm wide conductive trace made of CNT layer (2.9 µm thick) during 
“pre-stretching” cycles. Stable resistance was achieved between the 
fourth and fifth cycles here.
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Figure 4. Performance of piezocapacitive sensor. a) Capacitive device responsivity to uniaxial strain, ε (longitudinal). b) Normalized sensitivity or 
gauge factor of N = 4 capacitive devices. c) Sensor stability throughout 5000 stretching cycles at three strain points, 0%, 50%, and 100% of each cycle. 
Shaded area indicates the standard deviation (S.D.) for ± 5 cycles. d) Continuous recordings of the sensor response after the 1000th and 5000th cycles. 
Shaded area indicates the S.D. for ± 5 cycles.
Figure 5. Performance of a piezoresistive sensor. a) Resistive device responsivity to uniaxial strain, ε (longitudinal). b) Normalized sensitivity or gauge factor 
of N = 6 resistive devices. c) Sensor stability throughout 5000 stretching cycles at three strain points, 0%, 50%, and 100% of each cycle. Shaded area indi-
cates the S.D. for ± 5 cycles. d) Continuous recordings of the sensor response at the 1000th and 5000th cycles. Shaded area indicates the S.D. for ± 5 cycles.
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immersed in saline solution at body temperature at different 
time points including immediate, 10-h, 24-h, 48-h, and 1-week 
post-immersion. Next, the devices were kept soaked while 
being stretched under 0% to 100% longitudinal strain for 1000 
cycles. Then, the devices remained in the same condition for 
another three weeks (Figure 6). Except for the resistance meas-
urement after 1000 strain cycles post-one-week immersion, 
fluctuations of resistance were no larger than ± 27% and fluc-
tuations of capacitance were no larger than ± 23% observed 
during soaking. Additionally, we tested the resistance fluctua-
tion of the piezoresistor under room temperature which was 
much smaller than body temperature. Although stretchable 
CNT networks have been utilized as a conductor or semicon-
ductor material for many wearable electronics applications, 
this is the first successful demonstration of a CNT nanosheet-
based strain sensing device in a solution environment for 
potential implantable medical applications. Note that the elec-
trical stimulation interconnects were also made of the same 
width and thickness (0.5 mm wide, and 2.90 µm thick) and 
thus are expected to have a similar stability (Figure S5, Sup-
porting Information).
Capacitive versus Resistive Sensing Modes for Bladder Stimu-
lation: Based on our in vivo experiments discussed below, the 
biaxial range may be anywhere from around 45% to 90% strain 
in practice. This is approximately equivalent to a uniaxial strain 
of 54% to 110%. For the piezoresistive device, the worst drift 
observed was between the 1-week measurement and after 1000 
cycles. The drift at this point was 59%, but then recovered to 
27% higher than the initial value after 1-month total soaking. 
For the piezocapacitor, the drift over the same period was 15%. 
Percent variance after 1000 stretching cycles and 1-month 
soaking for the resistive and capacitive sensors was 27% and 
23%, respectively (N = 3 devices, Figure 6). However, a very crit-
ical difference between the two is the measurement circuit. A 
low-noise detection circuit for the resistor could be made with a 
simple voltage divider but accurately measuring a difference of 
2.1 pF per 1% strain difference is a more complex and sensitive 
circuit. In the latter case, even parasitic capacitance in the lead 
body and connector to the electronics housing could add signifi-
cant drift to the total capacitance.
The required accuracy and drift limits for a useful implant-
able sensor is not yet clearly defined. The simplest require-
ment is the detection of the point when the bladder is nearing 
its full state, which ideally is well before full to allow a patient 
time and convenience to manage the emptying of their 
bladder. In prior work, the liner correlation (Pearson correla-
tion coefficient) between an implantable pressure sensor and 
a catheter pressure sensor was on average better than r = 0.90. 
As we show below, we too have excellent correlation with 
resistance and volume, but that does not account for long-
term drift. These data taken as a whole suggest that a resistive 
device is likely to be an easier and more robust sensor and cir-
cuit to implement. Future work could further improve on our 
resistor performance by defining an optimal pre-cycling and 
pre-soaking regimen before chronic implantation. For these 
reasons, the in vivo measurements were taken using the resis-
tive type devices.
2.3. In Vivo Validation Including Biaxial Strain
We tested resistive devices during four anesthetized feline 
experiments. The devices were first sutured onto the bladder 
while the bladder was at approximately 1/3 of the bladder 
capacity. We placed devices at a partially full volume because 
the clinical utility is maximal from partial to full volumes as 
compared to near-empty volumes, and slight bladder tension 
facilitates the suture placement. 8–14 fill-empty cycles were 
conducted in each experiment, with the devices stretched up 
to the limit of the bladder volume at which leakage occurred. 
Table S1 in the Supporting Information shows the estimated 
biaxial strain among all four animals at their maximum 
bladder capacity. Maximum strain was limited by bladder 
leakage around the inserted catheter, and somewhat by place-
ment, so variability in the orthogonal and biaxial strain was 
considerable. One representative trial illustrates the correlation 
of resistance, strain, and pressure to volume which was con-
trolled with an infusion pump (Figure 7b). The strain, meas-
ured from the video footage of this same experiment (animal 
3), corresponded to approximately 49.6% longitudinal and 
30.2% transverse strain with no mechanical or electrical failure 
(Figure 7c). Furthermore, we show the repeatability of normal-
ized resistance versus volume for this same animal (N = 9 fill 
cycles, Figure 7d). Resistance is a measure of strain in that por-
tion of the bladder wall, especially biaxial strain (ΔS/S, where 
S is the area) of the device, and not necessarily linear with 
volume. The linear correlation coefficient for the mean of all 
cycles was measured to be 0.93 (nine trials in one feline) and 
could be greater than 0.99 when fit to an exponential equation 
(Figure 7d). Pressure is not linear to the bladder volume. As a 
point of comparison, implantable pressure sensors implanted 
into the wall of the bladder had an average correlation coeffi-
cient of about 0.90.[51,52]
Potential sensor output drift during a fixed strain condition 
was examined by both in vivo and bench-top studies. During an 
in vivo experiment, a feline bladder with a device attached was 
Adv. Healthcare Mater. 2019, 8, 1900477
Figure 6. Sensor stability test under physiological conditions. Both resis-
tive and capacitive device were immersed in PBS solution at 37 °C. The 
plot shows the resistance/capacitance change at different time points. 
N = 3 for each.
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held at a completely full state for 30 min. Piezoresistive sensor 
data were collected from two trials during which minor bladder 
size changes occurred based on video evidence. We meas-
ured < 10% change due to leakage, re-absorption, or self-filling 
(Figure S4a,b, Supporting Information). During the bench-top 
experiments, a device immersed in 37 °C PBS was held stretched 
at 25%, 50%, 75%, and 100% strain for 30 min each (Figure S4c, 
Supporting Information). The in vivo experiment trial 1 had a 
drift of less than 3.4% for a small bladder volume change, while 
trial 2 suggested that the device drifted more but also had a 
noticeable volume change. The bench-top experiment was a 
more precise means of testing drift, and demonstrated mean 
drift values from −1.1% to 1.3% over 30 min periods, which 
would be within the bounds required for a human application.
In one terminal experiment, we pushed the bladder capacity 
beyond the point of visible leakage at the urethra in an effort to 
understand the limits of the device and sutures at the last trial. 
Electrical failure was observed in this trial before any tearing 
was observed at the bladder by the tissue or the device. This 
failure point occurred when the observed biaxial strain was 
above 133% (corresponding to 64% and 53%, longitudinal and 
transverse, respectively).
2.4. Stimulation Electrodes and In Vivo Bladder Excitation
CNT can provide efficient charge transfer to tissue mainly 
because of its exceptionally high surface area.[53] However, 
given the potential cytotoxicity of CNT when directly released 
into tissue, a coating over the CNT has advantages.[54] Further-
more, we desired to limit the strain on the electrode by inte-
grating a stiffer elastomer with a mixture of Pt nanoparticles 
and Sylgard 184. To improve the charge capacity of the device, 
we utilized a nanocomposite previously demonstrated on an 
all-PDMS device and having gold interconnection.[55] Our Pt-
PDMS nanocomposite was screen printed (2-mm diameter and 
approximately 150 µm tall) into each electrode recess patterned 
on the encapsulating Ecoflex layer connecting to the CNT and 
Ti/Pt/Au layer on the bottom. Whether Pt-PDMS or CNT alone 
is a superior material is outside the scope of this report, but 
future studies should consider the biostability and toxicity of 
CNT as a direct stimulation material.
A four-point test structure was made to measure the contact 
resistance between the conductive composite and the metal/
CNT electrodes. The CNT resistance (2.90 ± 0.28 µm thick con-
trolled by the total mass of CNT deposited and 500-µm wide) 
was measured to be 0.9–5.5 kΩ as-deposited and 4.8–19.4 kΩ 
after pre-straining cycles. The contact resistance was lower 
than 50 Ω. The platinum-silicone composite turned out to have 
moderately low impedance (Figure S5, Supporting Informa-
tion, Zs = 77 ± 64 Ω∙cm2 at 1 kHz). The variation was caused 
by the non-uniform distribution of platinum microparticles 
inside the PDMS mesh. Unlike other demonstrations of the 
Pt-PDMS nanocomposite, we used reactive ion plasma etching 
to remove a thin layer of the top PDMS so that the surface of 
the embedded platinum particles could be exposed, which 
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Figure 7. In vivo sensor performance and stimulation induced contraction. a) Side views of device sutured on a feline bladder with 0, 30, and 50 mL 
liquid filled. Note the attached device does not create noticeable deformation of the bladder. b) CNT piezoresistor sensor output responding to the 
bladder volume during a fill to 50 mL with the accompanying bladder pressure. c) Longitudinal, transverse, and biaxial strain values of the device during 
the same trial using image analysis of top-down view. d) Mean sensor output across nine bladder filling trials in animal 3 (S.D. shaded in red). Linear 
and exponential fit relative to the delivered volume are shown with dashed lines. e) Stimulation-induced bladder contractions. All eight stimulation 
trials (light gray) overlaid with mean (black) and S.D. (light green) response.
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reduced the resistivity by five times. Electrode impedance was 
scanned from 10 Hz to 10 kHz in saline solution in a three-
electrode system. The total impedance of the stimulation elec-
trodes during soaking showed smaller fluctuation which was 
around 11% (Figure S5, Supporting Information). In order to 
ensure a repeatable waveform during stimulation, the future 
completely integrated system should use a current-mode pulse 
generator with high voltage compliance. Cyclic voltammetry was 
recorded in 0.15 m sulfuric acid over the range of −0.3 to +1.1 V 
versus Ag/AgCl electrode (scan rate 50 mV s−1). The composite 
showed 4.39 ± 2.64 mC cm−2 (Figure S5, Supporting Informa-
tion) cathodic charge storage capability, which was almost order 
of magnitude higher than a smooth platinum electrode.[56]
Electrical energy consumed on all the four electrodes during 
a stimulation event can be calculated using prior direct bladder 
stimulation and duration parameters for humans, such as 
10 mA, 300 µs pulse width and 40 Hz for 3 s.[10] At this level 
of current and our present interconnect geometry, a large com-
pliance voltage would be required, thus we should reduce 
the stimulation driving voltage to around 10 V by increasing 
our CNT trace thickness to 10 µm and width to 1 mm. These 
would be minor changes from our present fabrication process. 
Assuming the power consumption of a typical cardioverter defi-
brillator monitoring system as an estimation,[53] the device with 
a 350 mAh commercially available primary lithium battery for 
medical implant (EaglePicher LTC-3PN-M1), and eight bladder 
empty cycles per day, then the present materials and approximate 
design could potentially operate for over 7 yr without recharging.
Charge injection capacity and impedance as a function of the 
device strain did not change much because the PDMS mixed 
with high weight proportion of Pt microparticles was much 
stiffer than the surrounding Ecoflex 00–50. According to a 
COMSOL simulation (Figure S6, Supporting Information), for 
our particular geometries the expected maximum strain of the 
Pt-PDMS composite was below 5%. This may be an important 
advantage since stimulation for this application will only occur 
near the point of maximum strain and thus a Pt-Ecoflex com-
posite would have been significantly higher electrical resistance 
and limited current flow.
During an in vivo test, bipolar electrical stimulation was 
applied through the stretchable electrode on a piezoresistive 
device, using stimulation parameters of 33–50 Hz, 3 ms pulse 
width, and 1.25–2.5 mA. Before testing on the bladder, simply 
placing the device directly on the abdominal muscle allowed for 
robust recruitment of the somatic muscle during stimulation 
(Video 1, Supporting Information). Next, the device was placed 
on the exposed bladder before being sutured in place. After the 
bladder was filled to a near-full volume, 10-s epochs of stimula-
tion successfully induced bladder contractions, with increases of 
10.5–21.9 cm H2O observed (Figure 7e) from a baseline of about 
15 cm H2O. The pressure peaked at 6.8 ± 0.6s after initiation of 
stimulation. Effective bladder emptying in similar anesthetized 
feline experimental preparations has been reported at 37 cm 
H2O,[57] suggesting that the bladder responses driven here are 
capable of driving micturition. Larger contractions, of 50–80 cm 
H2O[58] and above 100 cm H2O[59] have been reported for non-
anesthetized animals. Future experiments will explore the 
optimal geometry to create robust bladder contractions. As the 
human bladder holds ten times the volume of feline bladders, 
there is sufficient area for a larger device or multiple devices. 
Furthermore, we chose a small rectangle for the simplicity of 
suturing in these studies, but the fabrication technology allows 
any arbitrary geometry such as a star shape to provide more 
access to multiple and specific locations on the bladder.
2.5. Packaging
The implantable application of CNT-based stretchable elec-
tronics was previously limited by two fundamental engineering 
concerns—the reliability of insulation and the robustness of 
wire bonding. In early proof-of-concept studies,[41,60] the wire 
connection from the CNT layer to an external circuit was 
achieved by conductive tape and a clamp, or wires were not 
allowed to stretch. However, in practical use by a surgeon, any 
device must perform well with noticeable strain on the leads 
and obviously have well-insulated solder joints. To address this 
issue, we developed a novel, robust, and low impedance elec-
trical interface from a medical grade superalloy, MP35N (Fort 
Wayne Metals) to the CNT layer. A 20 nm thin layer of Ti was 
first evaporated on the CNT layer to form a low resistance 
metal seeding at the wire-bonding region.[61] Secondly, a 50 nm 
Pt layer was evaporated above the Ti layer as a diffusion bar-
rier followed by a 300 nm thick Au layer on top to provide a 
strong and low resistance bonding interface. Next the MP35N 
alloy wire was bonded to the Au surface by applying silver paste 
(TED PELLA. Inc. 16 040-30) and low temperature annealing at 
120 °C. Finally, the wire bonding spot was completely encap-
sulated and secured by a layer of Ecoflex spun on top. Future 
work should study the potential toxicity of silicone encapsula-
tion of the fully sintered silver paste. Ag core wires are com-
monly used in medical devices, but additional encapsulation 
may be required around Ag paste.
The built-in strain relief of this technique was surprisingly 
robust. The wires themselves could be tugged (Figure S2, Sup-
porting Information) and there was no measured change in 
resistance even though the local stress to the bond pads was 
very high. As further demonstration of its mechanical tough-
ness, we clamped the wires and the distal end of the device 
to our motorized strain cycle apparatus and applied a longitu-
dinal strain of 50% for 100 cycles. Even though this test was 
aggressively applying stress directly to the wires and therefore 
the bond pads, the increase in total resistance was less than 5% 
in the piezoresistor circuit. So, whether this was a shift in the 
piezoresistor or the contact resistance, the wired interface is 
robust. Lastly, an important feature of the conductive layer was 
the capability of embedding them in the neutral plane of a rela-
tively thick MEMS device (300 µm). This theoretically allows 
the device to be bent without adding any stress in the conductor 
layer. We believe this fabrication solution contributed to the low 
open-circuit rate of this device during handling and the surgery 
implantation procedures.
3. Conclusion
In this study, we developed an implantable direct bladder inter-
face for strain sensing and bladder muscle stimulation using 
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low-durometer silicone, CNTs, a Pt-PDMS nanocomposite, 
and a medical-grade super alloy wire. Specifically, single- and 
double-layer CNTs were insulated by silicone (Ecoflex) to form 
highly stretchable and sensitive piezoresistive or piezocapaci-
tive sensing devices. We test both 100% uniaxial in benchtop 
tests and over 90% biaxial strain during in vivo tests. The Pt-
PDMS electrodes were screen-printed over CNT pads to form 
a stretchable electrode with the ability to deliver up to 3 mA of 
current. Additionally, a robust wire connection was integrated 
onto the device to make an array that has the potential to per-
form chronically. This device will enable a control system to 
drive bladder function through embedded logic and closed-loop 
control. While chronic in vivo validation is required, we hope 
this work inspires future medical device design for a bladder, 
cardiac, or gastrointestinal organ interface. For the SCI patient 
population in particular, having a robust sensor to notify them 
when their bladder or bowel is approaching full and driving 
micturition and continence would greatly improve their quality 
of life.
4. Experimental Section
Device Fabrication: To create the device, both conventional 
microelectronic fabrication technologies and a series of non-
conventional MEMS fabrication and packaging approaches were 
utilized as shown in Figure 2. For simplification, first the fabrication 
process of the resistive device was detailed. Starting from a 4″ silicon 
wafer substrate, an acetone dissolvable sacrificial layer was spun 
(Photoresist AZ-5240), followed by a 150-µm thick Ecoflex 00–50 layer 
(Smooth-on Inc.). Next, single-walled CNTs (Cheap Tubes Inc. Single 
Walled-Double Walled Carbon Nanotubes 99, 1–4 nm diameter and 
3–30um long) were mixed into IPA at 0.3 wt% and ultrasonicated for 
6 h. Next, the IPA solution with CNT was spray deposited[62] onto the top 
surface of the spun-on Ecoflex through a shadow mask. Next, Ti/Pt/Au 
was evaporated subsequently through the second shadow mask on top 
of the CNT pattern to define the wire bonding pads and the stimulation 
electrodes. Next, two layers of 100 µm-thick dry-film photoresist 
(DuPont Riston GM100) were laminated on top and patterned by 
photolithography. Then, another layer of 150 µm-thick Ecoflex 00–50 
was spun-on to complete the encapsulation of the conductors. 
Therefore, the CNT layer was encapsulated on the neutral plane, which 
prevented artifact strain induced by device bending or folding during 
handling or after implantation. 10 µm of the top surface of the whole 
structure was then etched by reactive ion plasma using SF6/O2 with 
LAM 9400.[63] After the top of the dry-film photoresist was exposed, 
the encapsulation Ecoflex layer was patterned by fully dissolving the 
dry-film photoresist. For piezocapacitive devices, an additional 5-µm 
thick insulating layer of Ecoflex 00–30 was spun coated between the 
lower and upper CNT layers. To access the lower pads of this device, a 
thinner-type dry film photoresist (MM540) and the same RIE-assisted 
lift-off process was used to pattern this insulating layer. Medical grade 
super alloy wires (MP35N PFA Green coated, Fort Wayne Wire) were 
bonded via silver paste reflow and sealed with additional Ecoflex. In 
the end, the device perimeter (23 mm by 12 mm) was defined manually 
with a razor blade but could have been laser cut. Then, the device was 
released by dissolving the sacrificial layer (Figure 2d,e) in acetone. 
Each sensor had an area of 9.6 mm by 4.8 mm. The stimulation 
electrode had a 2-mm diameter. Each suture point (patterned with 
CNT/Au circles) was 1-mm diameter. The use of CNT here was not 
necessary and could have been avoided to reduce exposure of tissue 
to CNT. Teflon Pledgets (Ethicon PCP50) were cut to a dimension of 
1.5 × 1.5 mm and added to the substrate prior to surgery by gluing 
with a small drop of Ecoflex 00–50 to reinforce each suture site.
Finally, Pt-microparticles and PDMS composite gel was screen-
printed into the electrode wells.[55] The Platinum microparticle and 
PDMS composite was prepared by mixing 60% PDMS (Sylgard 184, Dow 
Corning) with Platinum microparticles (Platinum powder, amorphous, 
< 3  µm, Alfa Aesar) by weight. PDMS was diluted in heptane in a 1:2 
ratio to reduce the viscosity. 60 mg of diluted PDMS was added to 80 mg 
platinum microparticles in a small centrifugal tube and mixed thoroughly 
with ultrasonication. The paste was then printed onto the formed CNT/Au 
electrodes with a shadow mask and left on a hot plate at 60 °C overnight 
to ensure complete polymerization. The composite was etched by oxygen 
plasma to remove the top PDMS so that more platinum can be exposed 
to deliver charge. The SEM image of electrode surface after preparation 
is shown in Figure S5 in the Supporting Information.
Mechanical Strain Testing: The sensor response to uniaxial strain 
under physiological conditions (37 °C PBS) was bench tested (Figures 4 
and 5). Deionized water was added to the solution every 6 h in order 
to negate the effect of evaporation. In all tests, the device was clamped 
horizontally with one end on a linear motor (Thorlabs, KMTS50E) and 
the other end on a 3D manipulator (Figure S3, Supporting Information). 
The devices were then stretched slowly from 0% to 100% strain and 
repeated for the number of reported cycles. The motor speed was 
0.8 mm s−1, or about 42 s per cycle. Resistance was actively recorded 
through a voltage divider circuit and sampled (Keithley 2410 and 
LabVIEW control program) at 54 samples s−1.
In Vivo Test Setup and Procedure: All procedures were approved 
by the University of Michigan Institutional Animal Care and Use 
Committee (IACUC), in accordance with the National Institute of 
Health’s guidelines for the care and use of laboratory animals. Four 
adult male felines (4.2–5.0 kg)were anesthetized and prepared for 
non-survival surgery as previously described.[64,65] With the animal in a 
supine position, the bladder was accessed via a laparotomy and slightly 
elevated above the abdomen to allow for clear visualization. Saline was 
applied to the bladder regularly to maintain tissue viability. A 3.5–4 Fr 
dual-lumen catheter was inserted into the bladder via the urethra for 
fluid infusion and pressure monitoring (Utah Medical DPT-100 pressure 
transducer, World Precision Instruments TBM4M transducer amplifier, 
AD Instruments PowerLab data acquisition). A piezoresistive device was 
sutured on the exposed bladder wall, with the wire end closer to the 
urethra and the other end positioned near the bladder dome (Figure 2f). 
Each pledget on a device was sutured with a single 5-0 nylon knot 
(661G, Ethicon). Each suture was applied within the bladder wall and 
did not pass into the bladder lumen. While suturing through the bladder 
wall may be acceptable for long-term implant validation, during short-
term experiments, it was found that fluid would leak around through-
wall sutures at high volumes. The device connections were placed in 
a simple voltage divider circuit, with a 5 V DC power supply providing 
current through the device and an in-series resister (≈100–350 kΩ). The 
voltage across the device was measured (AD Instruments PowerLab) 
and converted to resistance offline. Starting from an empty volume, 
saline was infused into the bladder at a constant rate (2–12 mL min−1) 
with a syringe pump until leaking from the urethra was observed. After a 
short hold period (≈30 s), the saline was withdrawn, and a fill cycle was 
repeated.
In Vivo Strain Calculation: The strain of the devices was analyzed 
from top-view videos recorded during in vivo studies using the MATLAB 
computer vision package. The MATLAB program detected the boundary, 
corners, and centers of the device implanted on a bladder. Biaxial strain 
was calculated from the change of the real-time device area under strain, 
which was estimated by the program through a total pixel count inside 
the device boundary. To analyze the strain in each direction, the program 
first defined the longitudinal and transverse directions by calculating 
the normalized vectors from corner to corner. Then, the expansion 
in either direction was calculated by the dot product of the real-time 
center-to-center electrode distance and the normalized vector. Finally, 
the longitudinal and transverse strain were calculated as the percentage 
device expansion in each direction. Maximum uniaxial and biaxial strain 
of each device was measured by this approach (Table S1, Supporting 
Information).
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Resistive Sensor Output Drift Testing: In an in vivo test, the animal 
and device were prepared same as described above. After device 
attachment, the bladder was filled to its maximum volume at which 
leakage through the urethra occurred. Then, the bladder was held at this 
volume for 30 min. Two trials during which no major size change (not 
more than 10%) happened were recorded and analyzed. The size change 
was estimated via pixel counting with a MATLAB script. A separate 
device was tested on the bench-top using the same protocol described 
above. Instead of stretching and releasing the device continuously and 
periodically, the device was stretched to 25%, 50%, 75%, and 100% 
strain and held for 30 min at each level.
Stimulation-Induced Bladder Contraction Experiment: In one 
experiment, electrical stimulation through the device was performed. 
Bipolar stimulation (isolated pulse stimulator model 2100, A-M 
Systems) was applied between two of the electrode contacts on the 
device. First, the device was laid on the exposed abdominal muscle, 
after a midline incision in the skin. Low-frequency (3 Hz) and higher 
frequency (33 Hz) stimulation was applied at 1 mA through the device to 
demonstrate recruitment of somatic muscle. Next, after a midline 
incision through the abdominal muscle was performed to expose the 
bladder, the device was placed on the bladder dome for evaluation of 
different stimulation parameters (33–50 Hz, 1.5–2.5 mA, 3 ms pulse 
width). A urethra catheter placed inside the bladder was connected to 
a transducer (Utah Medical DPT-100) for monitoring bladder pressure, 
with an amplifier (World Precision Instruments TBM4M) and data 
acquisition system (AD Instruments PowerLab) used to store data on 
a computer.
Statistical Analysis: The data labeled as “Normalized” in Figures 3–5, 
and 7 were calculated by dividing the measured values at each specific 
strain by the values at 0% strain. In Figures 4a and 5a, the mean and 
standard deviation was calculated from the whole 5000 stretching cycles 
as shown in Figures 4c and 5c. In Figures 4c, d and 5c, d, the data 
were smoothed by a slide window averaging of five cycles to reduce the 
influence of the mechanical and thermal noise. In Figure 6, the mean 
and standard deviation was calculated from N = 3 devices. In Figure 7d, 
e, mean and standard deviation was calculated from the filling/voiding 
and stimulation trials, respectively. The correlation value, R, was 
Pearson’s or the Pearson R test.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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